Total Payments
$10,110
2024 Payments
$1,421
Companies
56
Transactions
557
Medicare Patients
2,699
Medicare Billing
$187,427
Payment Breakdown by Category
Food & Beverage$9,919 (98.1%)
Education$191.01 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,919 | 554 | 98.1% |
| Education | $191.01 | 3 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,156 | 54 | $0 (2024) |
| Novo Nordisk Inc | $827.42 | 52 | $0 (2024) |
| Lilly USA, LLC | $768.30 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $752.82 | 22 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $666.59 | 44 | $0 (2024) |
| ABBVIE INC. | $599.65 | 49 | $0 (2024) |
| Astellas Pharma US Inc | $532.64 | 22 | $0 (2024) |
| PFIZER INC. | $487.85 | 30 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $409.16 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $400.30 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,421 | 72 | Novo Nordisk Inc ($181.53) |
| 2023 | $1,284 | 80 | Lilly USA, LLC ($171.07) |
| 2022 | $1,587 | 98 | ABBVIE INC. ($313.92) |
| 2021 | $1,077 | 64 | Lilly USA, LLC ($155.89) |
| 2020 | $1,013 | 59 | AstraZeneca Pharmaceuticals LP ($155.43) |
| 2019 | $1,208 | 50 | AstraZeneca Pharmaceuticals LP ($312.86) |
| 2018 | $1,115 | 63 | AstraZeneca Pharmaceuticals LP ($189.83) |
| 2017 | $1,405 | 71 | Janssen Pharmaceuticals, Inc ($382.38) |
All Payment Transactions
557 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: VACCINES | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Genetic Disease | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Biological | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Vaccines | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Biological | ||||||
| 09/30/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Cardio-renal | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: DIABETES | ||||||
| 09/06/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 467 | 794 | $56,280 | $32,423 |
| 2022 | 16 | 657 | 1,090 | $68,604 | $42,274 |
| 2021 | 24 | 763 | 1,216 | $83,320 | $51,709 |
| 2020 | 23 | 812 | 1,389 | $118,931 | $61,021 |
Total Patients
2,699
Total Services
4,489
Medicare Billing
$187,427
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 189 | $20,660 | $10,970 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 123 | $17,971 | $9,587 | 53.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $7,729 | $7,037 | 91.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $2,675 | $1,720 | 64.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,072 | $739.44 | 69.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 60 | 83 | $665.25 | $638.07 | 95.9% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 37 | 68 | $1,598 | $628.32 | 39.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 57 | $1,441 | $569.80 | 39.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 22 | 22 | $418.00 | $370.48 | 88.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 17 | 21 | $735.00 | $121.65 | 16.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 20 | 100 | $1,000 | $39.01 | 3.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 21 | $315.00 | $2.00 | 0.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 179 | $24,043 | $15,589 | 64.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 204 | $20,100 | $11,542 | 57.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $7,063 | $6,502 | 92.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 32 | $3,424 | $2,125 | 62.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $2,590 | $1,496 | 57.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 36 | $1,152 | $950.25 | 82.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 51 | 51 | $990.00 | $868.19 | 87.7% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 43 | 87 | $2,045 | $834.55 | 40.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 43 | 43 | $827.00 | $744.67 | 90.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 40 | 71 | $1,774 | $669.62 | 37.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 11 | 14 | $994.00 | $422.04 | 42.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 78 | 101 | $782.75 | $291.05 | 37.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 22 | 27 | $945.00 | $118.62 | 12.6% |
About Dr. Akashia Anderson, M.D
Dr. Akashia Anderson, M.D is a Family Medicine healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003075862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Akashia Anderson, M.D has received a total of $10,110 in payments from pharmaceutical and medical device companies, with $1,421 received in 2024. These payments were reported across 557 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($9,919).
As a Medicare-enrolled provider, Anderson has provided services to 2,699 Medicare beneficiaries, totaling 4,489 services with total Medicare billing of $187,427. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Murfreesboro, TN
- Active Since 06/06/2008
- Last Updated 07/10/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003075862
Products in Payments
- FARXIGA (Drug) $901.86
- JARDIANCE (Drug) $621.52
- ENTRESTO (Drug) $511.47
- XARELTO (Drug) $456.44
- XIFAXAN (Drug) $424.79
- VRAYLAR (Drug) $366.86
- Ozempic (Drug) $327.01
- INVOKANA (Drug) $290.36
- TRINTELLIX (Drug) $260.29
- Rybelsus (Drug) $248.28
- ELIQUIS (Drug) $241.63
- BELSOMRA (Drug) $219.26
- UBRELVY (Drug) $200.07
- Kerendia (Drug) $198.47
- NUEDEXTA (Drug) $183.39
- LEQVIO (Drug) $155.12
- MOUNJARO (Drug) $146.26
- SOLIQUA (Drug) $135.60
- MYRBETRIQ (Drug) $131.96
- APTIOM (Drug) $125.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Murfreesboro
Dr. Scott Eller, M.d, M.D
Family Medicine — Payments: $18,623
Family Medicine $18,623
Dr. Thomas Helton, Md, MD
Family Medicine — Payments: $15,111
Family Medicine $15,111
Dr. Laura Born, Md, MD
Family Medicine — Payments: $13,627
Family Medicine $13,627
Dr. Adam Childs, M.d, M.D
Family Medicine — Payments: $13,253
Family Medicine $13,253
Dennis Carter, Md, MD
Family Medicine — Payments: $11,679
Family Medicine $11,679
Nicholas Cote, D.o, D.O
Family Medicine — Payments: $10,359
Family Medicine $10,359